«We saw clearance of the virus at concentrations of BX795 that were five times lower than concentrations of antiviral compounds in
available nucleoside analogs,» Shukla said.
Not exact matches
Currently
available drugs to treat HSV - 1 infection work by preventing the virus from producing the proteins it needs to replicate and are known as
nucleoside analogs.